• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, August 1, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

UNF professor awarded US patent to fight cancer tumors using synthetic curcumin analogs

Bioengineer by Bioengineer
March 3, 2021
in Chemistry
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: University of North Florida

Dr. Kenneth Laali, University of North Florida Presidential Professor of Chemistry, has recently been awarded a US patent for his research on the synthesis of novel curcumin analogs (curcuminoids) to fight cancer tumors.

The compounds that Laali has developed provide novel therapeutic opportunities for specific cancers and may also aid in the discovery of therapeutics for multiple diseases.

His patent on “Novel ‘Curcuminoid-Inspired’ Synthetic Compounds as Anti-tumor Agents” discloses the synthesis and characterization of structurally diverse libraries of “curcumin-inspired” compounds (CURs), and reports on their anti-tumor activity against a host of cancer cell lines. Through these studies, he and his research group synthesized and characterized over 120 new compounds, and in the process discovered a number of “hit-compounds” that are effective not only in stopping cancer cell growth but also killing cancer cells and are therefore suitable for pre-clinical development.

This new patent is the culmination of over five years of Laali’s research at UNF with contributions by UNF undergraduates, master’s level research interns, and visiting scientists. His work has provided prominent research opportunities for UNF students, several of whom went on to pursue doctoral degrees at R1 Institutions. To date, seven peer-reviewed publications have resulted from this work and one made the cover of the journal ChemMedChem.

Laali hopes this patent, along with another one that is pending, could attract a pharmaceutical company for development of new anti-cancer compounds and therapeutics.

Laali is the inventor of two other UNF patents. He has authored and coauthored over 220 peer-reviewed publications, several books and monographs. Laali has been at UNF since 2009 and was the founding chair of the chemistry department. His research focuses on organic chemistry utilizing multifaceted projects that combine synthetic, structural/mechanistic, spectroscopic, and theoretical approaches to solving diverse problems in biological chemistry, green chemistry, and materials chemistry.

Prior to coming to UNF, Laali began his academic career at Kent State University in 1985 and rose through the ranks becoming full professor in 1996. He earned his doctoral degree from the University of Manchester in the United Kingdom and completed postdoctoral appointments at King’s College London, University of Strasbourg, University of Amsterdam, ETH-Zurich and University of Southern California.

###

About University of North Florida

UNF is a nationally ranked university in Jacksonville, Florida, nestled on a beautiful 1,300-acre nature preserve, featuring six colleges of distinction as well as nationally recognized flagship programs, with 60 bachelor degree programs and over 75 areas of concentration. UNF offers a unique student-centered academic experience that is creating the next generation of thinkers, leaders and problem solvers. More information at http://www.unf.edu.

Media Contact:

Amanda Ennis

Media Relations Coordinator

University of North Florida

(904) 620-2192

[email protected]

Media Contact
Amanda Ennis
[email protected]

Tags: cancerChemistry/Physics/Materials SciencesMedicine/HealthPharmaceutical ChemistryPharmaceutical SciencePharmaceutical SciencesPharmaceutical/Combinatorial Chemistry
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Nanodevice Harnesses Sound Waves to Shape Light, Revolutionizing Displays and Imaging Technologies

August 1, 2025
Here’s a rewritten version of the headline for a science magazine post: “Could Desert Dust Hold the Key to Freezing Clouds?”

Here’s a rewritten version of the headline for a science magazine post: “Could Desert Dust Hold the Key to Freezing Clouds?”

July 31, 2025

Rice Theoretical Physicist Illuminates Rare High-Field Phase in Superconductivity Research

July 31, 2025

Sunlight Transforms the Chemical Breakdown of Discarded Face Masks

July 31, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    37 shares
    Share 15 Tweet 9
  • Sustainability Accelerator Chooses 41 Promising Projects Poised for Rapid Scale-Up

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

CYBDOM Proteins Boost Plant Drought Resistance via Autophagy

Boosting Tumor Control: Radiation and ATR Inhibitor Trial

Neonatal Ultrasound: Training, Credentialing, and Quality Guidelines

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.